AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. IOVA
  4. [SCHEDULE 13G/A] Iovance Biotherapeutics, Inc. SEC Filing

[SCHEDULE 13G/A] Iovance Biotherapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock IOVA logo
Iovance Biotherp

NASDAQ:IOVA

IOVA Rankings

#2787 Ranked by Market Cap
N/A Ranked by Dividends

IOVA Latest News

Aug 29, 2025
Iovance Biotherapeutics to Present at Upcoming Conferences
Aug 22, 2025
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Aug 18, 2025
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Aug 7, 2025
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
Jul 24, 2025
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025

IOVA Latest SEC Filings

Aug 29, 2025
[8-K] Iovance Biotherapeutics, Inc. Reports Material Event
Aug 22, 2025
[8-K] Iovance Biotherapeutics, Inc. Reports Material Event
Aug 22, 2025
[424B5] Iovance Biotherapeutics, Inc. Prospectus Supplement (Debt Securities)
Aug 19, 2025
[8-K] Iovance Biotherapeutics, Inc. Reports Material Event
Aug 8, 2025
[Form 4] Iovance Biotherapeutics, Inc. Insider Trading Activity

IOVA Stock Data

875.69M
331.64M
0.35%
69.38%
19.8%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN CARLOS